HANGZHOU, China, Dec. 11, 2023 /PRNewswire/ — A report from Xinhuanet North America: 

With "Implementing the Global Civilization Initiative, Promoting Exchanges and Mutual Learning Between Civilizations" as its theme, the forum has attracted global attention with more than 300 guests from home and abroad

The first Liangzhu Forum, one of the key forums to support the higher-quality and higher-level construction of the Belt and Road Initiative (BRI), ended last week in Hangzhou, the capital of east China’s Zhejiang Province.

With "Implementing the Global Civilization Initiative, Promoting Exchanges and Mutual Learning Between Civilizations" as its theme, the forum has attracted global attention with more than 300 guests from home and abroad.

Chinese President Xi Jinping sent a congratulatory letter to the forum. "The ruins of Liangzhu ancient city are a demonstration of the 5,000-year history of the Chinese civilization and a treasure of world civilizations."

Representatives from the Silk Road International Theatre Alliance, International Museum Alliance, International Art Festival Alliance, International Library Alliance, International Art Museum Alliance, Tourism Cities Alliance, and international cultural and artistic institutions delivered speeches at the forum.

"Greece and China are both ancient civilizations, and both can benefit from recognizing and appreciating each other’s cultural treasures," said Stella Chryssoulaki, general director of Heraklion Archaeological Museum.

Besides the main forum, two sub-forums addressing worldwide sinologists and artists’ impressions of Chinese civilization also took place.

Albert Tadeusz Kozik, assistant professor of the Sinology Department of Warsaw University, said cultural exchange activities between China and Poland are becoming increasingly abundant.

Wu Weishan, curator of the National Art Museum of China, has created over 50 sculptures with the theme of Confucius and other outstanding Chinese historical figures and were showcased worldwide. "In the future, I will continue to promote mutual learning between Chinese and foreign civilizations through sculpture art and actively promote Chinese culture to the world stage," said Wu said.

The "Silk Road Artists’ Rendezvous" exhibition kicked off during the period. As a key sideline event of the Liangzhu Forum, 152 artworks of 84 artists from 83 countries are on show. From late November, foreign artists visited several Chinese cities, including Hangzhou, Huzhou and Shaoxing. Since 2009, hundreds of artists from nearly 100 countries have participated in similar "Silk Road Artists’ Rendezvous" visits to China.

Jointly held by the Ministry of Culture and Tourism, the People’s Government of Zhejiang Province and China International Culture Association, the first Liangzhu Forum aims to deepen mutual understanding and turn the Global Civilization Initiative into action.

Source : Liangzhu Forum Enhances Cultural Exchanges among Silk Road Countries

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

DUBAI, UAE, Dec. 11, 2023 /PRNewswire/ — Bybit, the world’s third-largest crypto exchange by volume, unveils the "USDC Wintry Draw" campaign, offering a total prize pool of 75,000 USDC.

Earn Big This Winter: Bybit and USDC’s Wintry Draw Offers Exciting Rewards

This event, running from Dec. 11, 2023, to Jan. 10, 2024, invites participants to engage in USDC derivative trading and sizable USDC deposits for a chance to win substantial rewards. Participants can trade USDC Derivatives at least four times with a minimum volume of $10,000 for a chance to win. Non-VIP users depositing $50,000 USDC and maintaining it for seven days are eligible to win $500 USDC, on a first-come, first-serve basis, up to a total of $20,000.

Bybit’s "USDC Wintry Draw" campaign reflects its strategic vision to integrate USDC into its diverse product offerings, including spot, options, and perpetual contracts. Through this campaign, Bybit aims to attract both retail and institutional participants, showcasing its ability to operate as a leading crypto exchange while supporting the expansion of USDC. This initiative is a significant move towards enhancing Bybit’s offerings, reinforcing its position as a gateway for innovative, USDC-settled products.

"We’re thrilled to launch the USDC Wintry Draw, providing our users with exciting opportunities to earn rewards on the Crypto Ark this winter," said Ben Zhou, co-founder and CEO of Bybit. "This campaign is a testament to our ongoing efforts to enhance user experience and promote USDC-settled products."

Enter the competition here

#Bybit / #TheCryptoArk

About Bybit

Bybit is a top-three cryptocurrency exchange by volume with 20 million users established in 2018. It offers a professional platform where crypto investors and traders can find an ultra-fast matching engine, 24/7 customer service, and multilingual community support. Bybit is a proud partner of Formula One’s reigning Constructors’ and Drivers’ champions: the Oracle Red Bull Racing team.

For more details about Bybit, please visit Bybit Press.
For media inquiries, please contact: media@bybit.com
For more information, please visit: https://www.bybit.com
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X (Twitter) | Youtube

Source : Bybit and USDC's Wintry Draw Offers Exciting Rewards: Earn Big This Winter

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

GUANGZHOU, China, Dec. 11, 2023 /PRNewswire/ — Winter comes late in Guangzhou, where lush trees and blooming flowers still grace the gardens. It is in this beautiful City of Flowers the Global Mayors’ Forum is taking place. On December 8, the 2023 Global Mayors’ Forum, co-organized by the Chinese People’s Association for Friendship with Foreign Countries (CPAFFC), People’s Government of Guangzhou Municipality, United Cities and Local Governments (UCLG) and World Association of Major Metropolises (Metropolis), was kicked off in Guangzhou, attracting over 800 representatives representing 65 cities in 37 countries and 9 international organizations, including 23 incumbent governors or mayors. At the opening ceremony, speakers representing different cities and international organizations made remarks, recognizing the contribution of the Global Mayors’ Forum and the Guangzhou Award to urban innovation and sustainable development.

The theme of 2023 Global Mayors’ Forum is "High-quality Growth with Urban Innovation and City-to-city Cooperation". In the next two days, representatives from home and abroad will attend seven sub-forums to discuss topics of "Coordinated Development of Bay Areas and City Clusters", "High-Level Urban Opening-Up — Global Cities Evaluation", "Artificial Intelligence and Digital Economy", "Green Cities and Resilient Communities", "Urban Cultural and Historical Heritage", "New Philosophies in Urban Planning and Construction", "Urban Social Safety Nets and Community Governance", and participate in international exchanges activities including city tours and Mayors’Dialogue. They will explore new methods, concepts and ideas in promoting high-quality development of urban governance, and how to build high-quality partnership between cities to create a new era for development of global cities.

In recent years, Guangzhou has been promoting multilateral exchanges and cooperation at city level, establishing itself as a firm participant, active promoter and important contributor to the innovation of global urban governance. The opening of the 2023 Global Mayors’ Forum provides an showcase for Guangzhou to present China’s achievements of reform and opening-up to the wider world and an opportunity for the international community to witness such achievements.

Source : Global Mayors Gather in Guangzhou to Discuss Urban Innovation and Development Strategies

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

JAKARTA, Indonesia, Dec. 11, 2023 /PRNewswire/ — Globally acclaimed, Indonesia’s No.1 coocaa TV successfully secured the Guinness World Record for "Most people unboxing online and in a single venue simultaneously" on November 24, 2023, alongside supporters from 8 countries. Amid the rigors of the challenge, coocaa TV exemplified superlative craftsmanship through a robust 60cm product drop test, accentuating a pivotal element attributing to its profound resonance in the Indonesian market——High Quality. Join coocaa in witnessing the brand’s new glory and miracles during the globally anticipated Double 12 promotion.

Special gifts for a special moment with cherished memories. To celebrate this remarkable Guinness World Record, coocaa presents 1,000 custom Guinness notebooks and 200 Guinness-themed coocaa mascot Cobby pillows to its esteemed consumers both online and offline. To enhance the celebration, more gifts such as Netflix memberships and game controllers will be offered. Every honor bestowed upon coocaa belongs to each and every consumer and supporter. All these perks are intended to express gratitude for the ongoing and unwavering following, choice, and support extended to coocaa. Join coocaa in making this December a memorable and festive experience together.

Indonesia’s No.1 coocaa TV Share Honors of Guinness World Record Achievement with Consumers in 12.12 Event

It’s time to unveil the flagship product from coocaa for the highly anticipated Double 12 promotion – the 50Y72 TV. It boasts cutting-edge voice control technology with impressive features like lightning-fast responsiveness, precise 90° voice pickup, and an outstanding 97% voice recognition rate, ensuring a seamless tech experience. But that’s not all – the TV goes beyond by prioritizing your eye health with Flicker-Free and Low Blue Light. It seamlessly integrates into your daily life, providing a perfect blend of advanced technology and eye-friendly design. What makes the 50Y72 TV even more exciting is its integration with Google TV products, elevating your entertainment experience to new heights. Now, consumers can enjoy the perfect combination of innovative technology, eye care benefits, and a TV that seamlessly fits into lifestyle. Get ready to experience the future of home entertainment! More please visite: https://www.instagram.com/coocaaindonesia/ 

The top-notch product with the best market feedback. coocaa’s No.1 sales perfectly reflect its popularity among TV consumers. Thanks to all the support and trust from users, coocaa is ready for even more success and cool innovations worldwide. With a dedicated emphasis on ensuring user satisfaction, coocaa is all set to keep leading the way in the world of TVs.

Source : Indonesia's No.1 coocaa TV Share Honors of Guinness World Record Achievement with Consumers in 12.12 Event

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

VIEREMÄ, Finland, Dec. 11, 2023 /PRNewswire/ — The 20,000th PONSSE forest machine has been completed at Ponsse’s factory in Vieremä, Finland. After the celebration on 11 December, the PONSSE Bear harvester with PONSSE H8 harvester head will go to a Norwegian customer, Lågen Skogsdrift AS.

"It’s great to see that machine number 20,000 is coming to Norway and to a customer with whom we have good and long cooperation. Our market here in Norway is growing, and this year will be a new record year. The Bear harvester is an impressive machine – and now even more so with its new H8 harvester head. This contributes to our strength in the most demanding harvesting operations in Norway," says Carl-Henrik Hammar, Managing Director Ponsse AB and Ponsse AS

Lågen Skogsdrift AS entrepreneurs have decades of experience in forestry

Lågen Skogsdrift AS is owned by brothers Harald and Gunnar Evju. The company is in Svarstad in the south of Norway. The Lågen Skogsdrift AS operation area is Lågen valley and parts of Vestfold, Telemark and Buskerud Counties. Harald and Gunnar Evju operate in the forest one week and rest the next.

The brothers are long-term Ponsse customers – this is their eighth Ponsse machine. Harald bought his first Ponsse HS 15 in 1996. He already started working in the forest with a chainsaw in 1978, and his first harvester was a Logman, bought in 1993. In 2001, the brothers bought their first forest machine together. It was a PONSSE Ergo with 6 wheels and an H73 harvester head.

"Thank you for your trust from my side, too. We delivered the first PONSSE Bear harvester to Harald and Gunnar in January 2008, and this machine we are handing over today is their fifth PONSSE Bear," says Tom Sundby, Ponsse AS salesman, south and west Norway. "I think Harald could be the person in Norway who has cut the most timber in his working life. He has cut something between 1.1 and 1.2 million cubic metres so far," Sundby continues.  

PONSSE Bear – A specialist in heavy-duty harvesting

PONSSE Bear is the strongest harvester in the model series. The powerful engine, sturdy crane, two powerful work pumps and strong H8 harvester head make it an agile giant for large trees and stands. The new PONSSE H8 harvester head is the next generation’s harvester head equipped with the Active Speed function, which raises effectiveness and productivity to a whole new level, no matter what the tree diameter is. The combination of Bear and H8 is a profitable solution with low lifecycle costs.

CONTACT:

Marko Mattila, Ponsse Plc
Sales, Service and Marketing Director
Tel. +358 40 0596297, [email protected]

The following files are available for download:

https://news.cision.com/ponsse-oyj/i/ponsse20th-12,c3247622

ponsse20th-12

Source : Ponsse manufactures its 20,000th forest machine

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

–     A multi-center phase Ib/III study in China and the United States led by Professor Binghe Xu, MD, PhD, Academician of the Chinese Academy of Engineering

–     70% of the patients enrolled in phase Ib study were previously treated with CDK4/6 inhibitors 

–     Demonstrated a confirmed objective response rate (ORR) of 30% and a median progression-free survival (PFS) of 7.3 months

SHANGHAI and WARREN, N.J., Dec. 11, 2023 /PRNewswire/ — Laekna (2105.HK), a clinical-stage biotechnology company, announced reporting the results of a phase Ib study to evaluate the efficacy and safety of afuresertib plus fulvestrant in patients with locally advanced or metastatic HR+/HER2- breast cancer who failed standard of care therapies at the 2023 San Antonio Breast Cancer Symposium (SABCS) on December 8.

From May 2022 to April 2023, 20 patients (19 female and 1 male) with locally advanced or metastatic HR+/HER2- breast cancer who had failed 1-2 lines of endocrine therapy were enrolled in the Phase Ib study. The median duration of follow-up was 11 months.

As of October 16, 2023, the main study results are as follows:

–        70% of the patients were previously treated with CDK4/6 inhibitors.

–        Among the total patient population, the confirmed ORR was 30% (95% CI, 11.9, 54.3),  the median PFS was 7.3 months (95% CI, 3.7, NE). The disease control rate (DCR) was 80%.

–        Among the 11 patients with specific biomarker alterations (PIK3CA/AKT1/PTEN), the confirmed objective response rate was 45.4% (95% CI, 16.7, 76.6), the disease control rate was 82%, and the median PFS was 7.3 months (95% CI, 3.6, 8.2).

–        Among the 17 Chinese patients, the confirmed ORR was 29.4% (95% CI, 10.3, 60.0), the disease control rate was 82.4%,  and the median PFS was 7.3 months (95% CI, 3.6, 8.2).

–        The results demonstrated a well-tolerated safety profile of afuresertib plus fulvestrant. No dose modification was required during the safety run-in period. No patient discontinued treatment due to TEAE. No serious adverse event (SAE) was reported. 

Investigators concluded that the combination therapy of afuresertib and fulvestrant has shown promising efficacy with a well-tolerated safety profile, supporting further evaluation in the upcoming Phase III part of the study.

Academician Binghe Xu, the lead investigator of the study, said: "While therapies for breast cancer are increasing, the treatment of drug resistance remains one of the clinical challenges. With the approval of the world’s first AKT inhibitor last month, patients with locally advanced or metastatic HR+/HER2- breast cancer now have new hope. The Phase Ib data of the combination therapy of afuresertib and fulvestrant are promising. I look forward to the next Phase III study of afuresertib in breast cancer."

"Biomarkers of response and/or resistance to endocrine-based therapies has become a prominent topic in the field of breast cancer treatment. It is also the central theme of the ‘Poster Spotlight Session’ in which our study was presented," said Dr. Yong Yue, Chief Medical Officer of Laekna. "Compared with the PFS data of 3-4 months for fulvestrant monotherapy[1], the median PFS of afuresertib plus fulvestrant is significantly increased to 7.3 months, with a favorable safety profile."

Lakena has initiated the Phase III pivotal trial of afuresertib plus fulvestrant in the treatment of HR+/HER2- breast cancer. The company strives to bring new hope to patients.

Notes

Breast cancer

The latest data released by the International Agency for Research on Cancer (IARC) of the World Health Organization show that the number of new cases of breast cancer in 2020 reached 2.26 million worldwide, surpassing lung cancer for the first time and becoming the world’s most prevalent cancer with 685,000 deaths. The latest epidemic data of malignant tumors in China also show that breast cancer has ranked first among women, with about 420,000 new cases each year[2].

Approximately 69% of breast cancer patients in the United States are considered HR+/HER2[3], and the proportion of this subtype among Chinese patients is 62%[4]. Although most patients with this type of breast cancer initially benefit from first/second-line endocrine ± CDK4/6 inhibitors and/or chemotherapy, most may develop drug resistance after a period, leading to treatment failure.

With further research on AKT, it has been demonstrated that factors such as PTEN loss and AKT/PIK3CA mutation can lead to excessive activation of the AKT signaling pathway, resulting in the occurrence, development, and drug resistance of tumors, especially prevalent in HR+ breast cancer. AKT has consequently emerged as a popular target for treating tumors.

Afuresertib

Afuresertib (LAE002) is an AKT inhibitor developed by Laekna. Laekna has initiated multiple clinical studies of combination therapies with Afuresertib in patients with PROC, HR+/HER2− breast cancer, mCRPC, TNBC, PD-1-resistant cervical cancer, and endometrial cancer.

—End—

About Laekna

Founded in 2016, Laekna is a science-driven, clinical-stage biotechnology company committed to bringing novel therapies to cancer and liver fibrosis patients worldwide.

As of June 30, 2023, Laekna has initiated six clinical trials for afuresertib (LAE002), LAE001 and LAE005 to address unmet medical needs in cancers, such as ovarian cancer, breast cancer and prostate cancer. Among the six clinical trials, three are multi-regional clinical trials (MRCTs), including one pivotal trial.

Laekna’s internal drug discovery platform has discovered 12 drug candidates. LAE102 is our first internally discovered antibody that has obtained an IND approval from the FDA. Its potential indications include muscle regeneration, obesity, and cancer.

Laekna, Inc. was listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange") on June 29, 2023. The stock code is 2105.HK.

For more information, please visit: https://www.laekna.com/

or https://www.linkedin.com/company/74110713/

Forward Looking Statements

This press release may contain certain "forward-looking statements" which are not historical facts, but instead are predictions about future events based on Laekna’s current beliefs, assumptions, and expectations, commonly identified by words such as "would", "may", "expects", "believes", "plans", "intends", "projects" and other terms with similar meaning. Although we believe that our predictions are reasonable, future events are inherently uncertain and our actual future results or performance may be materially different from what we expect. Accordingly, you are strongly cautioned that reliance on any forward-looking statements is subject to significant known and unknown risks and uncertainties. All forward-looking statements contained herein are qualified by reference to the cautionary statements set forth in this section. All information provided in this press release is as of the date of this press release and are based on assumptions that we believe to be reasonable as of this date, and we do not undertake any obligation to update any forward-looking statement, except as required under applicable law.

[1] N Engl J Med 2023;388:2058-70.

[2] Global Cancer. IARC. http://gco.iaic.fr/

[3] Cancer Stat Facts: Female Breast Cancer Subtypes; SEER 22 2016–2020

[4] Breast cancer subtypes and survival in Chinese women with operable primary breast cancer. Chin J Cancer Res, 2011. 23(2): p. 134-9.

Source : 2023 SABCS | Laekna Reports Afuresertib Phase Ib Breast Cancer Study Results

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

SAN FRANCISCO and SINGAPORE, Dec. 11, 2023 /PRNewswire/ — Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced the appointment of Angèle Maki, Ph.D., as Chief Business Officer, effective immediately.

Piers Ingram, Ph.D., Chief Executive Officer and co-founder of Hummingbird Bioscience said: "We are delighted that Angèle is joining our team. Her deep experience as a business development leader combined with her proven ability to execute on strategic transactions in biotech and pharma, makes her invaluable to our journey in bringing precision medicines to patients."

Dr. Maki has two decades of experience in the biotech and pharma industry, with a track record of successful deals and partnerships across multiple therapeutic areas and modalities including significant numbers in antibody therapeutics. Most recently, she served as Senior Vice President and Head of Business Development at ReCode Therapeutics, where she led business development, corporate development, investor and public relations. At ReCode Therapeutics, she was part of the team that raised a USD 120Mn series B extension. Prior to ReCode, Dr. Maki held business development roles with increasing responsibility starting at Medarex followed by BMS (which acquired Medarex), Genentech, Merck & Co, and Eli Lilly.

"I am excited to join Piers, Jerome, and the Hummingbird Bio Board of Directors and investors in driving the mission of delivering precision therapeutics to patients with unmet need. I believe Hummingbird Bio’s approach to precision medicines and its promising clinical antibody assets will redefine the next generation of precision therapeutics," said Dr. Maki.

About Hummingbird Bioscience

Hummingbird Bioscience is a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases. The Hummingbird Bioscience model combines computational and systems biology with wet lab drug discovery in a multi-disciplinary, collaborative environment spanning initial discovery through clinical development. The company harnesses this integrated approach across target identification and patient selection, enabling the team to increase the efficiency of translating novel scientific insights while reducing the inherent risk in drug discovery and development. The company is currently developing two clinical-stage assets: HMBD-001, a humanized anti-HER3 monoclonal antibody targeting a novel epitope on HER3, and HMBD-002, a humanized anti-VISTA IgG4 monoclonal antibody. Both programs are currently in Phase I studies. At Hummingbird Bioscience, the commitment to rigorous science, teamwork, and intellectual integrity underpins our passion to accelerate the journey of new drugs from concept to clinic. 

For more information, please visit www.hummingbirdbioscience.com, and follow Hummingbird Bioscience on LinkedIn, X (formerly Twitter), and YouTube.

Source : Hummingbird Bioscience Strengthens Leadership Team with Appointment of Angèle Maki as Chief Business Officer

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

HONG KONG, Dec. 11, 2023 /PRNewswire/ —

T Galleria by DFS, Macau, The Londoner store is celebrating its grand first year store opening anniversary. Sands Lifestyle, in collaboration with DFS, are co-hosting Little Luxury Stars children’s fashion event. DFS is offering guests a range of exclusive shopping offers at Shoppes at Londoner, along with various anniversary celebration activities.

DFS celebrates the first anniversary of the store opening with a lively cake cutting ceremony.

T Galleria by DFS, Macau, The Londoner is gearing up for a grand first anniversary of its store opening. To celebrate, DFS has launched various winter promotions and reward activities, adding an extra festive atmosphere to the Christmas season. Coinciding with the celebration, DFS, in conjunction with Shoppes at Londoner and Sands Lifestyle has launched a children’s fashion extravaganza, ‘Little Luxury Stars’. The family-friendly campaign, which commenced on December 9, includes a children’s fashion show, a range of limited-time shopping privileges and engaging in-store promotions, with a colourful London Zoo inspired decorative environment throughout the mall tying it all together.

Little Luxury Stars decoration is thoughtfully crafted, exuding both elegance and warmth.

Little Luxury Stars Kid’s Fashion Show Takes to the Stage

Little Luxury Stars was first launched at Marina Bay Sands, Singapore, and has been warmly received by shoppers and the city’s young fashion icons. By bringing the event to Macao it has now evolved into a synergistic regional event.

The event kicked off with a premium ready-to-wear children’s fashion show on December 9, that began with a ribbon-cutting ceremony, and a delightful opening dance performance featuring charming children dressed as Royal Guards and adorable animals. This was followed by 20 young fashionistas walking the runway vibrantly showcasing the latest seasonal looks that are all available at T Galleria by DFS at Shoppes at Londoner. Highlighted brands included Balmain, Bonpoint, Boss, Chloe, Givenchy, Kenzo Kids, Moncler, Moschino, Stella McCartney and Versace Kids.

The children’s fashion show was a captivating moment, filled with wonder and excitement.

The children’s fashion show was a captivating moment, filled with wonder and excitement.

Johan Pretorius, President of Hong Kong and Macao, DFS Group said, "We are delighted to celebrate the first anniversary of our store opening at The Londoner Macao and are thrilled to partner with Sands Lifestyle on launching the first Little Luxury Stars Kid’s Fashion Show in Macau. We take our brand promise seriously in being our customers’ personal guide to a world of luxury. Shoppers looking to indulge during this festive season can count on us to deliver an unforgettable curated experience when shopping at DFS The Londoner Store."

Timothy Jones, Senior Vice President of Retail, Sands China Ltd. said, "At Shoppes at Londoner, a premium lifestyle mall with a family focus, we are always looking to exceed shoppers’ expectations by arranging special promotions and events. With Christmas just around the corner, this is the perfect time to launch Little Luxury Stars, providing shoppers with a host of on-trend ideas for fashionable gifts. I would like to thank DFS for their invaluable support in making this inaugural fashion event so engaging and rewarding for the entire family. Following the kick off of this fashion extravaganza, Harry Potter™: The Exhibition will open on December 15 at The Londoner Macao, giving visitors even more family-friendly options."

The event finale with a perfect mark in the form of a group photo.

DFS The Londoner store features over 120 world-leading and emerging brands, including more than 50 beauty brands, 36 watch and sunglasses brands, and 40 plus kid’s fashion and toy brands, covering a total area of over 22,000 square feet. It is the epitome of a family-centric shopping destination that combines luxury shopping experiences and high-end lifestyles, accentuating DFS’s long-term partnership with Sands China Ltd.

A Season of Shopping with Abundant Rewards

Starting from December 9, DFS are offering a series of exclusive shopping benefits to customers at the Londoner Store Macao, providing them with the perfect opportunity to indulge in a luxurious shopping experience during this festive season.

The celebration of the store opening anniversary features numerous activities, including the Exclusive Lucky Capsule Game with a chance on winning grand prize with complimentary hotel room night and shopping vouchers. In addition to the joy of shopping, DFS has prepared a variety of engaging events for consumers, including chance of winning a Grand Prize of MOP 28,888 E-coupon, special performances by Santa Claus, Royal Guard music performances, animal mask painting workshops, balloon interactions, and more.

DFS features a children’s art workshop, providing an endless source of fun for families to enjoy a delightful and interactive journey together.

Completing the fashion-forward line-up is a Magical Shopping Spree promotion for Sands Rewards members, available until January 1, 2024. Spend MOP20,000 or more at Sands Shoppes Macao to earn up to MOP88,000 Rewards Dollar Vouchers and a stay at The Grand Suites at Four Seasons.

A series of diverse experiences await exploration throughout December, allowing you and your family to enjoy this warm season together.

DFS: Your Personal Guide To The World Of Luxury

DFS Group is the world’s leading luxury travel retailer. Established in Hong Kong in 1960, DFS Group continues to be a pioneer in global luxury travel retail, offering its customers a carefully curated selection of exceptional products from over 750 of the most desired brands. Its network consists of over 50 stores located in 15 major global airports and 21 downtown locations on 4 continents, as well as affiliate and resort locations. The Group is privately held and majority owned by the world’s largest luxury conglomerate, Moët Hennessy Louis Vuitton (LVMH), alongside DFS co-founder and shareholder Robert Miller. DFS Group employs more than 6,000 people focused on creating inspiring omnichannel retail experiences for its customers and is headquartered in Hong Kong SAR with offices in Australia, mainland China, France, Indonesia, Italy, Japan, Macau SAR, New Zealand, Singapore, United Arab Emirates, United States of America and Vietnam. For more information, please visit www.dfs.com.

About T Galleria by DFS

T Galleria by DFS is the ultimate evolution of the original travel retail concept pioneered by DFS Group. The first downtown store opened in 1968 in Hong Kong, followed shortly thereafter by Honolulu and eventually expanding to 21 locations all over the world. Today, T Galleria by DFS has a presence in the United States of America, as well as across Asia, Europe, Oceania and the South Pacific regions. Linked to the notion of travel through the use of T for the Traveler, the brand stands for what customers have come to expect: an expertly curated assortment of the world’s preferred luxury brands, exceptional retail environments, highly personalized services and unique experiences tailored to their specific needs as travelers. T Galleria by DFS enables travelers to realize their individual style, one journey at a time.

About Sands Shoppes Macao

Sands Shoppes Macao is the largest duty-free luxury shopping experience in Macao, with approximately 850 retailers featuring the world’s best brands, all under one roof. It consists of the interconnected Shoppes at Venetian, Shoppes at Four Seasons, Shoppes at Londoner and Shoppes at Parisian with a total over two million square feet of opulent retail space.

The luxury shopping experience is part of Sands China’s integrated resorts on the Cotai Strip, featuring seven hotel properties: The Venetian® Macao; The Parisian Macao; The Plaza™ Macao (including Four Seasons Hotel Macao, Cotai Strip); and The Londoner® Macao (comprising The St. Regis Macao; Conrad® Macao; and Sheraton Grand Macao; and The Londoner Hotel). Sands Shoppes Macao features some of Macao’s first-to-market luxury brands, and with its unique design themes, is an unmissable experience for visitors. Sands Shoppes Macao also delivers a wide array of delectable international cuisine, from high-end gourmet to expansive food court options.

 For more information, please visit http://en.sandsresortsmacao.com/shopping.html.

About The Londoner® Macao

The Londoner® Macao is an integrated resort that invites visitors on a journey through the best of British history and culture. It incorporates five celebrated hotel brands – the new The Londoner Hotel and Londoner Court, alongside existing Conrad Macao, Sheraton Grand Macao and The St. Regis Macao. The Londoner Macao will present visitors to Cotai with an expanded offering of affordable luxury available nowhere else in Macao, with over 6,000 hotel rooms and suites, and 1.2 million square feet (111,000 square metres) of retail, entertainment, dining and meetings and convention space. With over 150 retail outlets, Shoppes at Londoner joins Shoppes at Venetian and Shoppes at Four Seasons, alongside Shoppes at Parisian. Together they offer a selection of approximately 850 luxury duty free stores – the most in any one single location in Macao. With three spas, four health clubs and over 365,000 square feet (34,000 square metres) of uniquely themed gaming space, The Londoner Macao provides a new level of luxury and accessibility to the Cotai Strip.

Source : Co-hosting Little Luxury Stars at Shoppes at Londoner while T Galleria by DFS Celebrates First Anniversary in The Londoner Macao

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network